Ensayos clínicos

8.676 ensayos encontrados

Activo, no reclutaClinicalTrials.gov

Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis in Argentina.

OBSERVATIONALInicio: 20 de jun de 2025ID: NCT07080268

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase III, Open-label, Randomised, Multicentre Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations, and Whose Disease Has Progressed On or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy: LATIFY

INTERVENTIONALInicio: 15 de sept de 2022ID: NCT05450692

Activo, no reclutaClinicalTrials.gov

MAGenTA: Map of Tumor Genetic Actionability in Argentina

OBSERVATIONALInicio: 1 de abr de 2024ID: NCT06995235

Por invitaciónClinicalTrials.gov

Phenotypic Manifestations of Hereditary ATTR Amyloidosis Val50Met Variant in a Non-endemic Area. Descriptive Study

OBSERVATIONALInicio: 1 de sept de 2024ID: NCT07124377

ReclutandoClinicalTrials.gov

Institutional Registry of Haemorrhagic Hereditary Telangiectasia

OBSERVATIONALInicio: 1 de ene de 2010ID: NCT01761981

ReclutandoClinicalTrials.gov

Proof-of-Concept Case-Control Study for Hepatocellular Carcinoma Identification Using Delta-HLD Technology (HIDE)

OBSERVATIONALInicio: 18 de may de 2023ID: NCT07148310

CompletadoFase 3ClinicalTrials.gov

A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial

INTERVENTIONALInicio: 1 de abr de 2016ID: NCT02525939

ReclutandoFase 3ClinicalTrials.gov

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease

INTERVENTIONALInicio: 22 de nov de 2024ID: NCT05552157

ReclutandoClinicalTrials.gov

A Multi-national Real-world Outcomes and Treatment Patterns Study of Lanadelumab (Takhzyro) in Paediatric Patients With Hereditary Angioedema (TAHORA)

OBSERVATIONALInicio: 5 de feb de 2026ID: NCT07251933

CompletadoFase 3ClinicalTrials.gov

Human Pasteurized C1 Esterase Inhibitor Concentrate (CE1145) in Subjects With Congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks

INTERVENTIONALInicio: 1 de jun de 2005ID: NCT00168103

CompletadoClinicalTrials.gov

A Modified Case Control Study to Identify Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate

OBSERVATIONALInicio: 1 de may de 2009ID: NCT00890448

ReclutandoClinicalTrials.gov

Institutional Registry of Amyloidosis (Hospital Italiano de Buenos Aires)

OBSERVATIONALInicio: 1 de abr de 2011ID: NCT01347047

CompletadoFase 3ClinicalTrials.gov

Safety and Efficacy of Orally Administered Fx-1006A in Patients With Familial Amyloid Polyneuropathy (FAP): A Randomized, Double-blind, Placebo-controlled Study

INTERVENTIONALInicio: 1 de ene de 2007ID: NCT00409175

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled, Cross-over Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Attacks in Adolescents and Adults With Hereditary Angioedema

INTERVENTIONALInicio: 26 de feb de 2024ID: NCT06343779

CompletadoFase 3ClinicalTrials.gov

A PHASE 3 RANDOMIZED WITHDRAWAL, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 IN SUBJECTS AGED 12 YEARS AND OVER, WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH THE OPTION OF RESCUE TREATMENT IN FLARING SUBJECTS

INTERVENTIONALInicio: 11 de jun de 2018ID: NCT03627767

ReclutandoFase 2ClinicalTrials.gov

A Phase 1/Phase 2 Open-label Single Arm Study With Dose Escalation (Part A), and Dose Expansion (Part B) Parts to Evaluate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants 10 to 50 Years Old With Non-congenital Myotonic Dystrophy Type 1

INTERVENTIONALInicio: 23 de jul de 2025ID: NCT06844214

CompletadoClinicalTrials.gov

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).

OBSERVATIONALInicio: 1 de may de 2012ID: NCT01582763

ReclutandoFase 3ClinicalTrials.gov

Prospective, Multicenter, Randomized, Double-blind, Parallel Group, Placebo- Controlled, Efficacy and Safety Phase 3 Study of an Intravenous Human Plasma- Derived C1 Esterase Inhibitor (C1-INH) Concentrate in Participants With Congenital C1-INH Deficiency for the Treatment and Pre-procedure Prevention of Acute Hereditary Angioedema Attacks

INTERVENTIONALInicio: 30 de abr de 2024ID: NCT06361537

Por invitaciónFase 3ClinicalTrials.gov

A Phase II/III, Extension Study of Orally Administered PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

INTERVENTIONALInicio: 28 de dic de 2022ID: NCT05396105

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

INTERVENTIONALInicio: 1 de dic de 2024ID: NCT06669754